Antigenic modulation of measles subacute sclerosing panencephalitis virus in a persistently infected rat glioma cell line by monoclonal anti-haemagglutinin antibodies
Jutta Zinnheimer-Dreikorn and Klaus P. Koschel* Institut fiir Virologie und Immunbiologie der Universiti~t Wiirzburg, Versbacher Strasse 7, F.R.G. Rat glioma C6 cells persistently infected with measles subacute sclerosing panencephalitis (SSPE) virus (C6/SSPE) express the viral membrane proteins haemmagglutinin (HA) and F on their cell surface as well as the intracellular proteins N, P and M. Previously we have shown that the addition of a polyclonal antibody against the HA antigen to the growth medium of C6/SSPE cells led to a gradual loss of all viral antigens. Here we show that the addition of a monoclonal antibody (MAb K83) leads only to a transient decrease in viral antigens during the first three passages. After the third passage viral antigens start to increase and after five passages they produce more antigens than at the premodulation level. At this point of the MAb treatment, MAb K83 no longer recognized the HA antigen on the surface of the cells and in virus particles produced by these cells in contrast with polyclonal antibodies or other MAbs against the HA antigen. The results suggest that specific variants of the SSPE virus with an altered HA antigen were selected by the MAb treatment.
Originally, a loss of specific antigens from a cell surface after addition of specific antisera was described for leukaemia cells by Boyse et al. (1963) . A similar phenomenon takes place with acutely or persistently virus-infected cells, but in this case the specific antibodies against viral surface antigens also cause a loss of intracellular antigens from cells acutely infected with measles virus (Fujinami & Oldstone, 1979) and from rat glioma C6 cells persistently infected with measles subacute sclerosing panencephalitis (SSPE) virus (C6/SSPE) (Barrett et al., 1985) . This process was termed 'antigenic modulation by antiviral antibodies' (Fujinami & Oldstone, 1980; Fujinami et al., 1984) .
After such a 'modulating' treatment the cells were also no longer recognized by cytotoxic T cells or complement (Fujinami & Oldstone, 1986; Koschel et al., 1987) . After removal of antiserum viral antigens reappeared. This phenomenon of antigenic modulation is not simply due to a prevention of reinfection in a constantly growing cell culture via neutralization of produced virus by the antibody in the culture medium. Experimental evidence against such a hypothesis has been described earlier (Barrett et al., 1985) . The present data suggest rather that antigenic modulation is caused by capping, shedding and insertion of viral surface antigens (Barrett et al., 1985) . An inositol-phospholipid signal generated by the binding of antibody to the viral haemagglutinin (HA) antigen could also play a role in the down-regulation of the viral antigens (Weinmann-Dorsch & Koschel, 1989 ).
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To study the specificity of antigenic modulation monoclonal antibodies (MAbs) were used. In the case of HeLa cells acutely infected with measles virus, only MAbs against viral HA could modulate (Fujinami et al, 1984) , whereas MAbs against the viral fusion protein (F), another protein on the cell surface, did not have such an effect. MAbs against each of the other measles virus proteins could not modulate (Barrett et al., 1985) .
The present paper describes the modulation of viral proteins of C6/SSPE cells (rat glioma C6 cells persistently infected with measles SSPE virus) by MAb K83 (K83 was kindly provided by the laboratory of Professor V. ter Meulen of our Institute) (ter Meulen et al., 1981) . Previous studies have shown that HA in C6/SSPE cells is recognized by MAb K83. For modulation experiments, cells were grown in Dulbecco's modified Eagle's medium containing 50 haemagglutination inhibition (HAI) units/ ml of heat-inactivated (30 min for 56 °C) K83 MAb. After every second cell passage the cells were labelled with 25 ~tCi/ml [35S]methionine (sp. act. 800 Ci/mmol) overnight. After lysis in RIPA buffer (150 mM-NaC1, 10 mM-Tris-HC1 pH 7.5, 1 mM-EDTA, 1 ~ v/v NP40, 1 ~ w/v sodium deoxycholate, 0-1 ~ w/v SDS, 5 ~o v/v aprotinin), the lysate corresponding to 100 ~tg of total protein (protein determination according to Lowry et al., 1951) was immunoprecipitated by the addition of 2 l.tl of human measles antiserum and a 20 ~tl suspension of inactivated Staphylococcus aureus (Pansorbin, Calbiochem). The immunoprecipitated proteins were separated by electrophoresis on a 10~ polyacrylamide gel (Laemmli, 1970) and visualised by autoradiography. Viral proteins were quantified by densitometric evaluation ( Fig. 1 a) . Viral HA and N (nucleocapsid) protein decreased up to the third passage, but unexpectedly and in spite of the continuous presence of MAb K83, the HA and N antigens then increased in an over-shooting synthesis. A similar increased and over-shooting expression of viral antigens and viral RNA was observed after the removal of polyclonal antiviral serum from C6/SSPE cells after 18 passages in medium containing antiserum (data not shown). From the antigenic modulation experiments with MAb K83 it seems likely that the reexpressed HA antigen in C6/SSPE cells is no longer recognized by the modulating antibody. To test this hypothesis we tried with K83 to precipitate HA in lysates of K83-treated cells (Fig. 2, lane 5) as well as with polyclonal hyperimmune serum (Fig. 2, lane 6) ; K83 failed to precipitate HA from lysates of K83-treated cells after seven passages. However, K83 was still able to precipitate HA from lysates of non-modulated cells (lane 2). To study the modulation system we treated C6/SSPE ceils for seven passages with hyperimmune serum and looked for immunoprecipitation using MAb K83 (Fig. 2 treatment with hyperimmune serum compared with lane 1 (precipitation of lysates of untreated C6/SSPE cells with hyperimmune serum). The decrease in the amount of N protein is in good agreement with results published before where this protein disappeared after only l0 passages (Barrett & Koschel, 1983; Barrett et al., 1985) . Lanes 7 and 8 of Fig. 2 represent control immunoprecipitations using extracts from uninfected C6 cells. In addition, the immunofluorescence technique using K83 to detect HA on the surface of living cells shows that this viral protein can be recognized during the early phase of the experiment when it is disappearing, but not in the later phase where the viral proteins have started to increase in the presence of K83 in culture. Polyclonal antiviral sera, however, can recognize HA if present in all phases of the experiment.
These observations suggested that the HA epitope recognized by MAb K83 in some way altered during the antigenic modulation, leading to a situation where K83 did not bind to HA and therefore did not affect viral antigen expression.
To determine whether these epitope variants influenced the production of infectious virus we followed the release of infectious virus particles in C6/SSPE cell cultures during treatment with MAb K83. Due to the presence of only small amounts of virus in the supernatants of untreated and K83-treated C6/SSPE cells, virus was propagated for one growth cycle in Vero cells and finally tested for plaque formation (Fig. 1 b) . For plaque assay 200 ~tl of a series of 10-fold dilutions of virus samples were incubated on Vero cell monolayers (1 h at 5 ~ CO2 and 37 °C) and then overlaid with 2 ml of a 1 : 1 mixture of 2~o (w/v) agar and double concentrated MEM supplemented with 4~o foetal calf serum. Incubation followed for 4 days at 37 °C and 2.5~ CO2. The plaques were detected by staining with 0.01~ (w/v) neutral red in a mixture of 2~ agar with double concentrated MEM (1 : 1) overnight. Comparison of the data shown in Fig. 1 (b) and Fig. 1 (a) indicate that a correlation exists between the presence of viral antigens and the production of infectious virus particles. At the beginning of treatment with K83, the detection of viral antigens in C6/SSPE cells decreased as did the number of infectious virus particles whereas later, both increased rapidly during the continued presence of K83 in the growth medium.
To assess whether virus from K83-treated C6/SSPE ceils could be neutralized by the selecting antibody we performed neutralization assays with virus produced from untreated and K83-treated C6/SSPE cells. Both polyclonal SSPE antiserum and K83 MAb were used for these assays. The results are presented in Fig. 3 (a) . K83 was able to neutralize SSPE virus from untreated cells completely, but failed to neutralize K83-selected virus whereas both virus samples were neutralized by polyclonal antiserum. Therefore one has to assume that the HA epitope normally recognized by K83 has changed in the selected virus.
Furthermore, studies using MAbs toward different epitopes of the HA protein in virus neutralization assays have shown that these MAbs have similar neutralizing capacities against K83-selected virus than against normal viruses isolated from untreated C6/SSPE cells. For this purpose we used two MAbs from Dr E. Norrby's laboratory designated 141 and 16CD11 (Sheshberadaran & Norrby, 1986) . Results are demonstrated in Fig. 3(b) . Unselected and K83-selected SSPE virus were neutralized by both 141 and 16CDll.
A longer treatment of persistently infected C6/SSPE cells with polyclonal measles antiserum leads to the disappearance of the viral membrane proteins HA and F as well as of intracellular viral proteins N, P (RNA   120  I  I  I  I  I  I  I  I  I  I  I polymerase activity) and M (matrix protein) (Barrett & Koschel, 1983; Barrett et al., 1985) and only after removal of antiserum from growth medium do all viral proteins reappear. This communication shows that in the presence of HA epitope-specific MAbs the HA antigen is down-regulated. However, after some time in the continuous presence of the MAbs the HA antigen reappears in the cell membrane and in newly formed virus particles. This indicates that the HA molecules are changed in such a way that they are no longer recognized by the MAb. The reasons for the rapid appearance of such changed HA variants may be a high error rate of the viral RNA replicase, its lack of proofreading and selective pressure by the epitope-specific MAb.
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